MedTech sector outlook for 2025: RBC

RBC Capital Markets expresses optimism for the MedTech sector in 2025, highlighting growth opportunities driven by innovation, favorable demographics, and supportive policies.

Dexcom shares up as Diabetes Association updates guidelines

DexCom's shares rose as ADA updates recommend CGMs for more type 2 diabetes patients. Bank of America sees potential for insurance coverage and future growth with new products.

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.86%

Earnings call: DexCom reports steady growth with focus on CGM market expansion

DexCom reports 3% organic revenue growth in Q3 2024, total revenue of $994M, and aims for $4.6B by 2025 amid international market expansion.

After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more

The article discusses after-hours stock movements for several companies, highlighting significant gains and losses, including Capri Holdings' drop and Deckers Brands' rise.

DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth

DexCom's Q3 earnings beat expectations but stock dropped 16% due to slowed revenue growth; U.S. revenue declined while international sales increased.

Union Pacific, Dow Chemical, UPS lead earnings parade Thursday

A summary of companies reporting earnings on October 24, 2024, including estimates for EPS and revenue for various industry leaders.